基于双能CT的列线图预测胃癌淋巴结转移的诊断准确性
回顾性纳入210例经手术证实的胃癌患者,分为训练队列140例和验证队列70例,基于肿瘤厚度、Borrmann分型及静脉期碘浓度构建双能CT列线图预测淋巴结转移。内部验证队列AUC为0.793(95%CI 0.678-0.908),准确度0.757(95%CI 0.640-0.852),列线图对无进展生存和总生存也显示出预后能力。
要点
- 肿瘤厚度、Borrmann分型和静脉期碘浓度是胃癌淋巴结转移的独立预测因素。
- 基于双能CT碘定量的列线图内部验证AUC为0.793,准确度为0.757。
- 列线图对无进展生存和总生存的C-index分别为0.675和0.643。
核心结论
- 本研究提出的双能定量列线图可用于胃癌患者术前个体化预测淋巴结转移,并对无进展生存和总生存显示出预后能力。
研究设计与样本
- 回顾性研究,纳入210例经手术证实的胃癌患者(159例男性,51例女性;平均年龄59.8±7.7岁,范围28-79岁),分为训练队列140例和验证队列70例,采用光谱CT扫描,测量动脉期和静脉期原发肿瘤碘浓度并标准化至主动脉。
诊断标准与关键数值
- 列线图与淋巴结状态显著相关(p < 0.001);内部验证队列AUC为0.793(95%CI 0.678-0.908),准确度为0.757(95%CI 0.640-0.852);预后能力C-index:无进展生存0.675(95%CI 0.571-0.779;p < 0.001),总生存0.643(95%CI 0.518-0.768;p = 0.025)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and validate a dual-energy CT based nomogram for the preoperative prediction of lymph node metastasis (LNM) in patients with gastric cancer (GC).
METHODS: A total of 210 surgically confirmed GC patients (159 males, 51 females; mean age: 59.8 ± 7.7 years, range: 28-79 years) who underwent spectral CT scans were retrospectively enrolled and split into a primary cohort (n = 140) and validation cohort (n = 70). Clinical information and follow-up data including overall survival (OS) and progression-free survival (PFS) were collected. The iodine concentration (IC) of the primary tumors at the arterial phase (AP) and venous phase (VP) were measured and then normalized to the aorta (nICs). Univariate, multivariable logistic regression and Cox regression analyses were performed to screen predictive indicators for LNM and outcome. A nomogram for risk factors of LNM was developed, and its performance was measured using the ROC, accuracy and Harrell's concordance index (C-index).
RESULTS: Tumor thickness, Borrmann classification and ICVP were independent predictors of LNM. The nomogram was significantly associated with LN status (p < 0.001). It yielded an AUC of 0.793 [95% confidence interval (95% CI), 0.678-0.908] and an accuracy of 0.757 (95% CI, 0.640-0.852) in the internal-validation cohort. The nomogram also exhibited a prognostic ability with C-indices of 0.675 (95% CI, 0.571-0.779; p < 0.001) for PFS and 0.643 (95% CI, 0.518-0.768; p = 0.025) for OS.
CONCLUSION: This study presented a dual-energy quantification-based nomogram, which can be used to facilitate the preoperative individualized prediction of LNM in patients with GC.
KEY POINTS: • This study first developed and internally validated a dual-energy CT-based nomogram to predict lymph node metastasis in patients with gastric cancer. • The nomogram incorporated the clinical risk factors and iodine concentration, which would enable superior preoperative individual prediction of lymph node metastasis and add more information for the optimal therapeutic strategy. • The nomogram also exhibited a significant prognostic ability for progression-free and overall survival.
引用
- Li J, Fang M, Wang R, et al. Diagnostic accuracy of dual-energy CT-based nomograms to predict lymph node metastasis in gastric cancer. Eur Radiol. 2018. PMID: 29869176. doi:10.1007/s00330-018-5483-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。